ReWalk Robotics Ltd. (NASDAQ:RWLK) shares saw unusually-high trading volume on Wednesday . Approximately 139,151 shares traded hands during trading, an increase of 5% from the previous session’s volume of 132,197 shares.The stock last traded at $5.99 and had previously closed at $6.09.

RWLK has been the subject of several research analyst reports. Zacks Investment Research upgraded ReWalk Robotics from a “sell” rating to a “hold” rating in a research report on Thursday, April 28th. Jefferies Group reiterated a “buy” rating and issued a $16.00 price objective on shares of ReWalk Robotics in a research report on Sunday, May 8th. Piper Jaffray Cos. initiated coverage on ReWalk Robotics in a research report on Friday, July 15th. They issued an “overweight” rating and a $10.00 price objective for the company. Finally, Canaccord Genuity reiterated a “buy” rating on shares of ReWalk Robotics in a research report on Sunday, August 7th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $12.80.

The stock’s market capitalization is $71.65 million. The firm’s 50-day moving average price is $6.63 and its 200 day moving average price is $8.21.

ReWalk Robotics (NASDAQ:RWLK) last issued its quarterly earnings results on Thursday, August 4th. The medical device company reported ($0.64) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.53) by $0.11. The firm earned $0.82 million during the quarter, compared to analyst estimates of $1.95 million. The firm’s quarterly revenue was up 34.4% compared to the same quarter last year. On average, equities analysts forecast that ReWalk Robotics Ltd. will post ($2.34) EPS for the current year.

In other news, Director Wayne Weisman sold 100,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 16th. The stock was sold at an average price of $6.37, for a total value of $637,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jeff Dykan sold 11,370 shares of the business’s stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $7.74, for a total value of $88,003.80. The disclosure for this sale can be found here.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.